[Choice for the treatment of congestive heart failure].
D000284:Administration, Oral; D000450:Aldosterone / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology; D001783:Blood Flow Velocity; D003994:Bucladesine / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015150:Echocardiography, Doppler / Q000379:methods; D015716:Electrocardiography, Ambulatory; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010807:Physical Endurance / Q000187:drug effects; D011667:Pulmonary Veins / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D000450:Aldosterone; D003994:Bucladesine